The global assisted reproductive technology market was valued at $2,317.7 million in 2020 and is expected to increase at a CAGR of 19.3% from 2021 to 2030, reaching $12,272.5 million by 2030. Infertility is treated at fertility clinics and surgical centres using assisted reproductive technology such as in vitro fertilisation (IVF), artificial insemination (AI-IUI), and frozen embryo replacement.
The global assisted reproductive technology market is growing due to an increase in the prevalence of infertility, an increase in funding from private and government organisations for infertility services, an increase in awareness about infertility treatment and surrogacy, and an increase in assisted reproductive technology technology. According to the World Health Organisation (WHO), infertility will affect roughly 186 million individuals and 48 million couples in 2020. According to the Centres for Disease Control and Prevention (CDC), roughly 6% to 12% of PCOS-affected women in the United States also have an infertility issue. As the prevalence of PCOS rises, so does the risk of infertility, fueling the expansion of the assisted reproductive technology industry. TMRW Life Sciences, a life science technology business that provides a platform for tracking and monitoring, announced the debut of the world’s first automated frozen specimen management solution for eggs and embryos used in IVF in February 2021. Thus, technical innovation includes the use of software and imaging systems to track embryo growth on monitors. Furthermore, in 2018, LUMSA University in Italy unveiled the WoMoGeS (Women’s Movement and Gestational Surrogacy) project, which intends to educate disadvantaged women in poor countries about gestational surrogacy.
The market for assisted reproductive technology is divided into four sections: product, technology, end user, and region. The market is divided into three categories: instrument, accessory & disposable, and reagent & media. Instruments are further subdivided into sperm separation systems, cryosystems, incubators, imaging systems, ovum aspiration pumps, cabinets, micromanipulators, laser systems, and others. Cryopreservation media, semen processing media, ovum processing media, and embryo culture media are all subcategories of reagents and media.
Get a Free Sample Copy of a Research Report: https://analyticsmarketresearch.com/sample-request/assisted-reproductive-technology-market/76762/
Market Segmentation:
Procedure type: ART procedures include in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), surrogacy, artificial insemination, and others. Segmentation by procedure type can provide insights into the demand for specific ART procedures.
End-user: The ART market can be segmented by end-users, such as fertility clinics, hospitals, and others. This segmentation can provide insights into the demand for ART services by different types of healthcare providers.
Technology: The ART market can be segmented based on the type of technology used, such as fresh embryo transfer, frozen embryo transfer, and others. This segmentation can provide insights into the adoption rate of different technologies.
Geography: The ART market can also be segmented based on geography, including North America, Europe, Asia Pacific, and the Rest of the World. This segmentation can provide insights into regional demand for ART services.
Age group: The ART market can be segmented by age group, including women under 35, women between 35 and 40, women between 40 and 45, and women over 45. This segmentation can provide insights into the age-related demand for ART services.
Type of infertility: The ART market can be segmented by the type of infertility, such as male infertility, female infertility, and unexplained infertility. This segmentation can provide insights into the demand for ART services by different types of patients.
Key Player:
Vitrolife AB
CooperSurgical Inc. (A Subsidiary of The Cooper Companies Inc.)
Irvine Scientific Sales Company, Inc. (A Subsidiary of Fujifilm Holdings Corporation)
Cook Medical Inc.
Thermo Fisher Scientific Inc.
Genea Limited
Esco Micro Pte. Ltd.
Nidacon International AB
IVFtech ApS
The Baker Company Inc.
Purchase This Report: https://analyticsmarketresearch.com/purchase/assisted-reproductive-technology-market/76762/?license=single
Regional Analysis:
North America is the largest market for ART due to the high prevalence of infertility, advanced healthcare infrastructure, and favorable reimbursement policies. The United States accounts for a major share of the North American ART market. The Asia-Pacific region is also expected to grow significantly due to the increasing awareness about infertility treatments and rising healthcare expenditure.
Europe is another major market for ART due to the high prevalence of infertility and favorable government policies. The United Kingdom, Germany, and France are the major markets in this region.
Latin America and the Middle East and Africa are also expected to witness significant growth in the coming years due to the increasing adoption of ART and rising healthcare expenditure. However, the market growth may be hindered due to the high cost of ART treatments.
Key Points:
Assisted Reproductive Technology (ART) is a medical technology used to treat infertility by using advanced procedures to fertilize eggs outside of the body and then transfer them to the uterus for implantation.
The global ART market is expected to grow significantly in the coming years due to increasing infertility rates, growing awareness about ART procedures, and advancements in technology.
Some of the key technologies used in ART include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT).
The market is segmented by procedure type, technology, end user, and geography. IVF is the most common procedure type, while fertility clinics and hospitals are the major end users.
The Asia Pacific region is expected to see significant growth in the ART market due to increasing awareness, rising disposable income, and growing medical tourism in countries such as India and China.
Some of the major players in the ART market include CooperSurgical, Inc., Vitrolife AB, Cook Medical, Inc., Irvine Scientific, and Thermo Fisher Scientific, Inc.
The market is highly competitive, with companies focusing on product development, strategic collaborations, and mergers and acquisitions to expand their market presence.
However, the high cost of ART procedures and the lack of reimbursement in some regions are some of the major challenges faced by the market. There is also a growing concern about the ethical and social implications of ART, which may hinder market growth.
Get The Details Here: https://analyticsmarketresearch.com/reports/assisted-reproductive-technology-market/76762/
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
